Lv1
60 积分 2025-03-29 加入
SM08502, a novel, small-molecule CDC-like kinase (CLK) inhibitor, demonstrates strong inhibition of the Wnt signaling pathway and antitumor effects in diverse ovarian cancer models
1个月前
已关闭
Phase 1/2 Multicenter, Open-Label Study of CTX-712 in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
1个月前
已关闭
Genomic attributes of prostate cancer across primary and metastatic noncastrate and castrate resistant disease states: a next generation sequencing study of 183 patients
4个月前
已完结
The Selective CDK9 Inhibitor VIP152 Overcame Therapeutic Resistance in Mantle Cell Lymphoma
5个月前
已完结
Novel Multikinase Clk Inhibitor BH-30236 Targets Hematological Malignancies through Alternative Splicing Regulation
6个月前
已完结
Targeting CLK1/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy and immunotherapy
6个月前
已完结
Targeting CLK4 inhibits the metastasis and progression of breast cancer by inactivating TGF-β pathway
6个月前
已完结
Alternative splicing in prostate cancer
7个月前
已完结
Exploring the roles of the Cdc2-like kinases in cancers
11个月前
已完结
An overview of cdc2-like kinase 1 (Clk1) inhibitors and their therapeutic indications
11个月前
已完结
皖公网安备34019202002308
